Patients with diabetes may get a C-peptide test as a means of distinguishing type 1 diabetes from type 2 diabetes or Maturity onset diabetes of the young (MODY). Measuring C-peptide can help to determine how much of their own natural insulin a person is producing as C-peptide is secreted in equimolar amounts to insulin. C-peptide levels are measured instead of insulin levels because C-peptide can assess a person's own insulin secretion even if they receive insulin injections, and because the liver metabolizes a large and variable amount of insulin secreted into the portal vein but does not metabolize C-peptide, meaning blood C-peptide may be a better measure of portal insulin secretion than insulin itself.

This Arthritis Panel Includes Sedimentation Rate, Anti-Nuclear Antibody (ANA), Rheumatoid Factor, C-Reactive Protein (CRP), and Serum Uric Acid

This panel includes blood and urine tests commonly used by physicians to determine kidney dysfunction: Urinalysis, Comprehensive Metabolic Panel (CMP), Cystatin C and eGFR.

The A1c test works by measuring the hemoglobin A1c level. Hemoglobin is stored in the red blood cells. When glucose levels are high, the sugar starts to combine with the hemoglobin. It takes the body 8 to 12 weeks to bring hemoglobin A1c levels back to normal. Therefore, if hemoglobin A1c levels are high, that means that there has been a high level of glucose in the blood over the last 2 to 3 months.

A C-Reactive Protein (CRP) Quantitative test is used to aid in the diagnosis of infections or diseases which cause inflammation. CRP is a protein produced by the liver. Higher than normal concentrations of CRP are often an indicator of infection or inflammation in the body. This test can help determine if an infection is present but not the source of the infection. Conditions that can cause elevated CRP levels include but are not limited to Sepsis, Pelvic Inflammatory Disease, Arthritis, Lupus, Vasculitis, and Inflammatory Bowel Disease.